Oncotelic Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Oncotelic Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • Oncotelic Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 18, 2024 was 407M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 407M Nov 18, 2024 10-Q 2024-11-19
Q2 2024 406M +8.11M +2.04% Aug 11, 2024 10-Q 2024-08-14
Q1 2024 400M +6.81M +1.73% Apr 11, 2024 10-K 2024-04-12
Q3 2023 399M +8.08M +2.07% Nov 14, 2023 10-Q 2023-11-14
Q2 2023 398M +19.5M +5.16% Aug 11, 2023 10-Q 2023-08-18
Q1 2023 393M +14.2M +3.76% Apr 12, 2023 10-K/A 2023-04-20
Q3 2022 391M Nov 14, 2022 10-Q 2022-11-18
Q2 2022 379M +7.28M +1.96% May 16, 2022 10-Q 2022-05-23
Q1 2022 379M +287M +315% Mar 20, 2022 10-K 2022-04-15
Q4 2021 373M Nov 15, 2021 10-Q 2021-11-22
Q2 2021 371M +283M +319% Aug 10, 2021 10-Q 2021-08-20
Q1 2021 91.3M +4.25M +4.88% Apr 13, 2021 10-K 2021-04-15
Q3 2020 89.6M +7.15M +8.67% Nov 11, 2020 10-Q 2020-11-16
Q2 2020 88.6M Jun 24, 2020 10-Q 2020-06-29
Q1 2020 87M +45.6M +110% May 8, 2020 10-K 2020-05-14
Q4 2019 83.1M Nov 18, 2019 10-Q 2019-11-19
Q3 2019 82.5M +41M +99.1% Aug 19, 2019 10-Q 2019-08-19
Q1 2019 41.4M +250K +0.61% Apr 10, 2019 10-K 2019-04-10
Q3 2018 41.4M +14.9M +56% Nov 14, 2018 10-Q 2018-11-14
Q2 2018 41.4M +14.9M +56% Aug 14, 2018 10-Q 2018-08-14
Q1 2018 41.2M +14.6M +55.1% Apr 12, 2018 10-K 2018-04-17
Q3 2017 26.5M 0 0% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 26.5M 0 0% Jul 31, 2017 10-Q 2017-08-02
Q1 2017 26.5M 0 0% Mar 30, 2017 10-K 2017-03-30
Q3 2016 26.5M 0 0% Nov 10, 2016 10-Q 2016-11-14
Q2 2016 26.5M 0 0% Jul 29, 2016 10-Q 2016-08-02
Q1 2016 26.5M 0 0% Mar 23, 2016 10-K 2016-03-25
Q3 2015 26.5M +5.84M +28.2% Nov 10, 2015 10-Q 2015-11-12
Q2 2015 26.5M +5.84M +28.2% Jul 31, 2015 10-Q 2015-08-06
Q1 2015 26.5M +11.3M +74.2% Mar 25, 2015 10-K 2015-03-30
Q3 2014 20.7M +17.6M +561% Nov 10, 2014 10-Q 2014-11-13
Q2 2014 20.7M +18.1M +685% Aug 4, 2014 10-Q 2014-08-08
Q1 2014 15.2M +13.2M +641% Mar 17, 2014 10-K 2014-03-20
Q3 2013 3.13M -17.5M -84.8% Nov 6, 2013 10-Q 2013-11-13
Q2 2013 2.64M -14.9M -85% Aug 8, 2013 10-Q/A 2013-10-18
Q1 2013 2.06M -14.1M -87.3% Mar 1, 2013 10-K 2013-03-15
Q3 2012 20.6M +5.7M +38.3% Nov 2, 2012 10-Q 2012-11-09
Q2 2012 17.6M +3.21M +22.4% Aug 3, 2012 10-Q 2012-08-13
Q1 2012 16.2M Mar 22, 2012 10-K 2012-03-28
Q3 2011 14.9M Nov 4, 2011 10-Q 2011-11-10
Q2 2011 14.4M Aug 5, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.